AUTL

Autolus Therapeutics PLC

-$92.2M

Net Activity

Institutions Holding

84

Popularity Rank

#4838

Avg Weight

1.20%

Total Value

$184.8M

Ownership Trend

84 institutions currently hold AUTL, with 34 net buyers and 41 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

41

Net Buying Institutions

34

Key Holders

View all 84 holding institutions

Quarterly Activity

Recent Activity

+$83.4M

Total Buy Value

$82.3M

Total Sell Value

New buy10
Trim29
Add24
Sold out12

34

Net Buyers

41

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding AUTOLUS THERAPEUTICS PLC (AUTL)?
Major stakeholders currently include Mak Capital One LLC ($46.4M), Blackstone Inc. ($28.3M), Syncona Portfolio Ltd ($23.0M). Based on the latest 13F filings, there are a total of 84 tracked investment funds and institutions maintaining positions in AUTL.
What is the overall institutional sentiment toward AUTL recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $92.2M, driven by 34 managers accumulating shares while 41 reduced their exposure.
Which institutions have been selling or reducing their AUTL positions?
In the latest period, 29 funds trimmed their holdings, and 12 managers completely exited their positions. The aggregate reported sell value was $82.3M.
Are there any notable investors adding AUTL to their portfolios?
Yes, buying activity remains notable. 10 institutions opened new positions in {ticker}, and 24 existing holders added to their shares. The total reported buy value for the quarter amounted to $83.4M.

Related Stocks